merck glp-1 drug Merck's Keytruda faces challenge from Eli Lilly's drugs | Venkatesh N. posted on the topic Swiss Re says GLP-1 drugs
Description
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review
This long history of use provides strong evidence of their safety when prescribed and monitored by healthcare professionals
10.1038/natrevmats.2016.71
The study, International coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches, was published on August 16, 2024 in the Lancet
